Rafferty Asset Management, LLC Curis Inc Transaction History

Rafferty Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.31 - $5.13 $1.38 Million - $3.07 Million	-599,086 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$4.45 - $8.09 $1.08 Million - $1.96 Million	241,738 Added 67.65%	599,086 $2.85 Million
Q3 2021 Nov 10, 2021	BUY	$6.94 - $8.85 $219,956 - $280,491	31,694 Added 9.73%	357,348 $2.8 Million
Q2 2021 Aug 10, 2021	BUY	$7.45 - $16.27 $152,985 - $334,104	20,535 Added 6.73%	325,654 $2.63 Million
Q1 2021 May 10, 2021	BUY	$8.78 - $12.8 $2.68 Million - $3.91 Million	305,119 New	305,119 $3.45 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Rafferty Asset Management, LLC with notifications on news.